Fetterman’s overall health, return to campaign path a thriller as some Democrats grow ‘very nervous’ about Pa. Senate race

WASHINGTON — Pennsylvania Democratic Senate nominee John Fetterman does not have a timetable for returning to the campaign trail, sparking some worries in the party approximately a few months after he experienced a stroke and surgeons implanted a pacemaker with a defibrillator to control his heartbeat.

Fetterman, the state’s lieutenant governor, has appeared publicly only in recorded online video considering the fact that the stroke. His spouse is talking to the media on his behalf. And the scenario has prompted Democrats to refresh their expertise of state ballot-replacement regulation — the deadline is in August — in accordance to two party resources who claimed they really don’t anticipate a candidate switch staying vital.

Nevertheless, some of Fetterman’s fellow Democrats say they are concerned both equally about his wellbeing and what they explain as a deficiency of transparency from his staff about just what happened when he was hospitalized very last month. Days later, Fetterman won a contested major in a blowout, capturing all 67 counties.

There has been “no indication” of a timeline for Fetterman’s return to the path, reported an elected Pennsylvania Democrat who has interacted with Fetterman. “A lot of us Democratic Party forms are very anxious about it.” The official, who requested not to be named to steer clear of blowback from his bash, claimed Fetterman requires to be transparent both for the reason that it is the appropriate factor to do and fantastic politics.

Fetterman’s health and fitness and its political implications are no little issue for Democrats. Pennsylvania is widely seen as their party’s greatest decide on-up prospect in a midterm election cycle in which handle of the Senate hinges on the result of a handful of races. And his absence from the marketing campaign trail has robbed Democrats of a head commence towards the common election. The Republican primary is mired in a recount, with much less than a thousand votes separating Mehmet Oz — the movie star Television health practitioner with a history in cardiothoracic surgery — and former hedge fund executive Dave McCormick.

“I consider persons I’ve talked to — myself bundled — never know what to make of it,” said a veteran Pennsylvania Democratic strategist who requested anonymity to converse candidly about a delicate subject. “It’s not like Fetterman has shut institutional allies, so Dems are contacting all-around wanting to talk to the dilemma, but no clue exactly where to get

Read More

Medical device leader Medtronic joins race to bring AI to health care

Medtronic, the world’s largest medical device company, is significantly increasing its investments into AI and other technologies, in what it says is an effort to help the health care industry catch up with other industries.

While many other industries have embraced technology, health care has been slower. Studies reveal that only 20% of consumers would trust AI-generated health care advice.

VentureBeat interviewed Torod Neptune, Medtronic’s senior vice president and chief communications officer, and Gio Di Napoli, president of Medtronic’s Gastrointestinal Unit, to discuss the company’s vision of the future of health care technology.

Digital transformation in health care

Neptune spoke about Medtronic’s transition beyond traditional med tech to more innovative solutions using AI. He noted that health care technology — through its unusual scale and ability to harness data analytics, algorithms, and intelligence — plays a significant role in solving big problems in the AI field.

Artificial intelligence increases the detection of early cancer by 14% compared to normal colonoscopy, Di Napoli said. This is very important because “every percentage of increase in detection reduces the risk of cancer by 2%,” he said.

Building on Medtronic’s medical devices already serving millions (like its miniature pacemaker, smart insulin pump, and more), the company’s plan to make health care more predictive and personal led to the development of GI Genius Intelligent Endoscopy Module (granted USFDA de novo clearance on April 9, 2021, and launched on April 12, 2021).

Above: Medtronic says its GI Genius Intelligent Endoscopy Module is the first-to-market computer-aided polyp detection system powered by artificial intelligence.

The GI Genius module is the first and only artificial intelligence system for colonoscopy, according to Medtronic, assisting physicians in detecting precancerous growths and potentially addressing 19 million colonoscopies annually. The company says the module serves as a vigilant second observer, using sophisticated AI-powered technology to detect and highlight the presence of precancerous lesions with a visual marker in real time.

Investing in innovative health care

Medtronic has launched more than 190 health care technology products in the past 12 months. It also invests $2.5 billion yearly on research and development (R&D). Medtronic’s CEO, Geoff Martha, recently announced a 10% boost in R&D spending by FY22.

This enormous investment, the largest R&D increase in company history, underscores Medtronic’s focus on innovation and technology.

The company says it plans to expand the number of patients it serves each year, with the

Read More